Medicare Enrolled
Dr. Ronald Ebb, MD
Urology Physician · Leominster, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ebb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ebb?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ebb
Dr. Ronald Ebb is an urology physician in Leominster, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ebb performed 2,055 Medicare services across 1,492 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ebb received a total of $5,589 from 45 pharmaceutical and/or device companies across 232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ebb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 43% volume in MA
$5,589 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,055
Medicare services
Top 43% in MA for urology physician
1,492
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~103 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
561 | $65 | $251 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
524 | $8 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
196 | $88 | $310 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
183 | $3 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 174 | $135 | $250 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
96 | $193 | $650 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
91 | $78 | $440 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
55 | $19 | $180 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $107 | $470 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
29 | $28 | $60 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $41 | $210 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
19 | $327 | $960 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $82 | $755 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $104 | $350 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $139 | $472 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $565 | $1,700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
27.7% medium
71.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,589
Total received (2018-2024)
Avg $798/year across 7 years
Top 25% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
232
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,299 (94.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$290 (5.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,028
2023
$1,273
2022
$894
2021
$1,163
2020
$375
2019
$433
2018
$422
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$169
Astellas Pharma US Inc
$154
Janssen Biotech, Inc.
$100
ABBVIE INC.
$86
Sumitomo Pharma America, Inc.
$64
AstraZeneca Pharmaceuticals LP
$56
Merck Sharp & Dohme LLC
$55
Myriad Genetic Laboratories, Inc.
$47
PFIZER INC.
$45
Antares Pharma, Inc.
$40
Laborie Medical Technologies Corp.
$37
Telix Pharmaceuticals
$27
C. R. Bard, Inc. & Subsidiaries
$25
Boston Scientific Corporation
$24
Teleflex LLC
$23
Bayer Healthcare Pharmaceuticals Inc.
$23
Novartis Pharmaceuticals Corporation
$19
Endo USA, Inc.
$19
Ferring Pharmaceuticals Inc.
$16
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$771
Janssen Biotech, Inc.
$625
UROGEN PHARMA, INC.
$322
Endo Pharmaceuticals Inc.
$259
PFIZER INC.
$241
Axonics, Inc.
$240
Teleflex LLC
$225
AstraZeneca Pharmaceuticals LP
$223
Antares Pharma, Inc.
$213
Myriad Genetic Laboratories, Inc.
$177
PROCEPT BioRobotics Corporation
$169
Laborie Medical Technologies Corp.
$161
Sumitomo Pharma America, Inc.
$154
Acerus Pharmaceuticals Corporation
$149
Merck Sharp & Dohme LLC
$138
C. R. Bard, Inc. & Subsidiaries
$120
Boston Scientific Corporation
$112
NeoTract Inc.
$96
Avadel Specialty Pharmaceuticals, LLC
$88
ABBVIE INC.
$86
Bayer Healthcare Pharmaceuticals Inc.
$84
Medtronic USA, Inc.
$83
Supernus Pharmaceuticals, Inc.
$79
AbbVie Inc.
$67
Rochester Medical Corporation
$65
UROVANT SCIENCES INC
$65
Tolmar, Inc.
$61
AbbVie, Inc.
$57
Ferring Pharmaceuticals Inc.
$51
Blue Earth Diagnostics Limited
$51
Myovant Sciences Inc.
$45
Progenics Pharmaceuticals, Inc.
$37
Coloplast Corp
$36
Ethicon Inc.
$31
Merck Sharp & Dohme Corporation
$29
Telix Pharmaceuticals
$27
Foundation Medicine, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$20
Novartis Pharmaceuticals Corporation
$19
Endo USA, Inc.
$19
Allergan Inc.
$18
Accord Healthcare, Inc.
$18
Medtronic, Inc.
$16
Wilmington Medical Supply, Inc.
$16
TOLMAR Pharmaceuticals, Inc.
$11
Top 3 companies account for 30.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BRAC CDx · BRACANALYSIS CDX · Bard Urinary Drainage Bag · CAMCEVI · EDEX · ELIGARD · ERLEADA · FOUNDATIONONE · GEMTESA · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MAGIC3 · MYRISK · Monarch Platform · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PROLARIS · PYLARIFY · Prolaris · Rezum Generator · SKYLITE · SPEEDICATH · SpaceOAR VUE System - 10mL · SpeediCath · TOVIAZ · Tria Firm · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
46
Per 100K population
5.3
County median income
$93,561
Nearest hospital
UMASS MEMORIAL HEALTHALLIANCE HOSPITALS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ebb is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ebb experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ebb performed 561 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ebb receive payments from pharmaceutical companies?
Yes. Dr. Ebb received a total of $5,589 from 45 companies across 232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ebb's costs compare to other urology physicians in Leominster?
Dr. Ebb's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ebb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Leominster
Browse urology physicians in Leominster ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
UROGEN PHARMA, INC. Payments to Doctors
See all physicians who received payments from UROGEN PHARMA, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology